Effective FIP treatment

1 capsule every 12 hours per 2.5 kg of body weight, ideally on an empty stomach. If vomiting occurs within 30 minutes, administer another capsule.

Molnupiravir EIDD-1931 is not recommended for neurological cases, cats with a history of digestive problems, cats in critical condition, or treatments lasting longer than 60 days.

Avoid the following medications: CYP Enzyme Inhibitors: Certain antifungals (e.g., ketoconazole) Antibiotics (e.g., erythromycin) Other medications (e.g., ritonavir) CYP Enzyme Inducers: Rifampin Certain antiepileptics (e.g., phenytoin) Medications Affecting Renal Excretion: NSAIDs Certain diuretics Some antibiotics (e.g., aminoglycosides) Drugs That Prolong the QT Interval: Certain antipsychotics Antiarrhythmics Antibiotics like macrolides and fluoroquinolones Other Antiviral Drugs: Careful evaluation is needed to avoid antagonistic effects or increased toxicity.

By adhering to our prescribed treatment protocol, including specific dosage and frequency, you can expect an approximate 97% success rate in treatment.

Absolutely, our EIDD-1931 medication is conveniently encapsulated in powder form. Simply place the capsule behind your cat's tongue or mix it with their wet food.

FIP is a highly lethal disease in cats with no chance of natural recovery. Cats diagnosed with FIP typically reach a critical condition within a week due to the disease's rapid progression, and without treatment, it is invariably fatal. The cost of a full GS-441524 treatment course in the United States is high, excluding veterinary fees.However, molnupiravir EIDD-1931 offers a more effective and affordable solution for this devastating condition. This treatment is 4.4x more effective than EIDD-2801 and 7.3x more effective than GS-441524, ensuring rapid recovery with significant improvement seen within a week. It also has lower cytotoxicity, making it safer for prolonged use, and boasts a near-zero relapse rate, providing lasting peace of mind. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7114919/#:~:text=FIP%20is%20a%20fatal%20immune,found%20in%20cats%20%5B4%5D.

This treatment is suitable for all cats except those exhibiting ocular or neurological symptoms, are in critical conditions, lacking appetite, or have liver and kidney pre-existing condition or FIP related complications. In such instances, we recommend using GS-441524 until these conditions are resolved before using EIDD-1931. To Purchase GS-441524 visit: https://www.curefip.com

Yes, we do. Molnupiravir EIDD-1931 has been used as cure and proven to be highly effective in treating FIP. Studies have shown that it is 4.4x more effective than EIDD-2801 and 7.3x more effective than GS-441524. These studies demonstrate significant improvement in cats within a week of treatment, with a near-zero relapse rate and lower cytotoxicity, making it a safe and reliable option for feline infectious peritonitis. Link: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9227765/

Molnupiravir, commercially known as EIDD-2801, is a prodrug commonly used to treat COVID-19 in humans. Upon ingestion by humans or animals, EIDD-2801 is converted by the body into its active form, EIDD-1931. Clinical research conducted in the USA and China has shown that EIDD-1931 is 4.4 times more potent than EIDD-2801 in its mutagenic effect against the feline infectious peritonitis (FIP) virus. Additionally, EIDD-1931 exhibits 33% lower cytotoxicity in in vitro tests. These findings suggest that EIDD-1931 is a more preferable drug for treating FIP due to its higher potency and lower cytotoxicity.

A clinical study published by the National Institutes of Health states that 46.2% of cats exhibit clinical signs of improvement within the first week, 84.6% within two weeks, and 92% by the third week. This is a good representation of real world treatment results. Link: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9612227/

No, Molnupiravir EIDD-1931 treatment is recommended for a maximum of 60 days. You can start with the first 30 days and consult with your veterinarian for further guidance.

MolnuFIP™ EIDD-1931 is most effective for early to mid-stage FIP. For cats in late stages or with severe symptoms, it is recommended to start with GS-441524 injections. You can purchase GS-441524 at CUREFIP.COM . You can transition to EIDD-1931 once their condition stabilizes. MolnuFIP™ EIDD-1931 : https://www.molnufip.com/product-page CUREFIP Website: https://www.curefip.com

Yes, it is the most cost effective treatment against FIP available today. A 30 days treatment course starts from $39, which is approximately 10x cheaper than alternative FIP treatments GS-441524.

No, avoid drugs known to prolong the QT interval, such as certain antipsychotics, antiarrhythmics, and antibiotics like macrolides and fluoroquinolones, as they may pose a risk when taken with Molnupiravir EIDD-1931.

EIDD-1931, a variant of Molnupiravir, garnered public attention in early 2023 following a series of independent clinical studies conducted by researchers worldwide. These studies demonstrated its effectiveness against feline infectious peritonitis (FIP).

EIDD-1931

Yes, avoid combining MolnuFIP™ EIDD-1931 with soda tablets, sodium bicarbonate, hydroxide tablets, sucralfate, and other alkaline treatments during the treatment period.

Combining antiviral drugs can sometimes lead to antagonistic effects or increased toxicity. Carefully evaluate potential interactions with other antivirals before combining them with Molnupiravir EIDD-1931.

MolnuFIP™ EIDD-1931 is suitable for all types of cats with FIP symptoms. Our EIDD-1931 is a definite cure for Wet FIP (Effusive), Dry FIP(and non-effusive), cats with fever, loss of appetite, ascites, pleural effusion, diarrhea, jaundice.

The pharmacokinetics of MolnuFIP™ EIDD-1931 are as follows: C_max: 5.49 ± 0.90 µg/ml T_max: 2.00 ± 1.10 h T_1/2: 4.83 ± 0.72 h AUC_0-t: 38.88 ± 3.92 mg/ml * h

MolnuFIP™ Treatment provides 60 capsules, each with 15 mg of EIDD-1931.

Yes, avoid NSAIDs, certain diuretics, and some antibiotics (e.g., aminoglycosides) as they can impact the renal excretion of EIDD-1931.

EIDD-1931 was developed by Emory Institute for Drug Development, hence the acronym EIDD. Link: https://eidd.emory.edu/

Up to 60 days or as recommended by a veterinarian.

No, avoid CYP enzyme inhibitors like certain antifungals (e.g., ketoconazole), antibiotics (e.g., erythromycin), and other medications (e.g., ritonavir), as well as CYP inducers such as rifampin and certain antiepileptics (e.g., phenytoin). These can affect the metabolism of EIDD-1931.

Our molnupiravir is provided in size 3 capsules with off white powder.

EIDD-1931 is a ribonucleoside analog that incorporates itself into viral RNA during replication, causing mutations that inhibit viral replication (lethal mutagenesis).

Finish treatment in 60 days.

It comes in easy-to-use tiny soft gel capsules that can be swallowed whole, mixed with food, or administered directly.

Store MolnuFIP™ EIDD-1931 in a dry, cool place away from sunlight.

It is 4.4x more potent than EIDD-2801.

Recovery starts within a week.

MolnuFIP™ EIDD-1931 is significantly more effective and safer than EIDD-2801. EIDD-1931 is 4x more potent and has lower cytotoxicity, making it better suited for long-term FIP treatment in cats. While EIDD-2801 is used for FIP due to its availability, EIDD-1931 offers more superior efficacy and fewer side effects, ensuring a more successful and comfortable treatment for your cat.

Our molnupiravir ( EIDD-1931 ) has shown 97% treatment success rate in FIP treatment in several countries.

The expiration period for MolnuFIP™ EIDD-1931 is 24 months.

No, there is no known drug resistance.

MolnuFIP™ EIDD-1931 is packaged as 60 soft gel capsules in a vacuum-sealed mylar bag.

MolnuFIP™ EIDD-1931 is not recommended for: Ocular or neurological cases Cats not feeding or defecating normally Cats with a history of poor dietary absorption